본문 바로가기

Immune Cell Therapy

Immune Cell Therapy is designed to activate NK cells which will distinguish and fight against cancer cells.

Tokyo Cell Clinic's Immune Cell Therapy : AKC™

AKC™ (Autologous Killer Cell) means self-activated lymphocyte. AKC Immune Cell Therapy is to inject activated immunocyte : NK cells, T cells of lymphocyte extracted from collected blood.
NK cells are capable of detecting cancer cells and destroying them, and AKC™ Immune Cell Therapy is designed to multiply and activate NK cells, which will be injected to kill cancer cells and improve your immune system.

Blood Collection - Isolation of Lymphocyte, Plasma - Activation - Infusion - Washout and Harvest - Proliferation

Effects of AKC™ Immune Cell Therapy

Cancer patients' bodies have a less capability of eliminating cancer cells because the activated degree of the patients' immune systems is only 25 % of healthy people's. It is proven that people, whose NK cells are more active, have less possibility of suffering from cancers. Also, an experiment, to compare a body with highly active NK cells and another body with less active NK cells, showed that the percentage of cancers occurrence on people with less active NK cells was doubled.

Ability to remove cancer cells

J.Korean Aced Fam Med, 2008, 29(4),Suppl.

Immune activity in cancer patients is 25% of healthy people.
Cancer incidence according to NK activity

'NK cytotoxic activity of peripheral-blood lymphocytes cancer incidence' lmai K, Matsuyama S, Miyake S, Suga K, Nakachi K,
Lancet 2000)

NK activity is low, the incidence of cancer is doubled.

Tokyo Cell Clinic has its own NK cell culture technique, which requires a high level of expertise and knowledge in the field.
NK Cells releases a type of proteins, so-called porphyrins to make a hole where granzymes go into to destroy the cancer cells. On top of that, NK Cells also trigger, another kind of proteins, trails to induce the suicide of cancer cells.

NK cell, Cancer cell
Ability to remove cancer cells

AKC enables the bodies to have a far greater ability to fight against cancer cells by inducing more than 90 percent of porphyrins and granzymes, and more than 40 percent of trails. In the case of cancer patients with a weaker immune system, it is vital to activate NK cells through the treatment because their bodies have less NK cells or their cells are not fully activated to destroy cancer cells.